Wagner Charles F Jr sold 15,286 shares of VERTEX PHARMACEUTICALS INC MA at $547.87 for −$8.37M on Nov 12, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
EVP, CO & FO
EVP, CO & FO
Filed Nov 16, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$8,374,740.82Shares × reported price
Shares traded
15,286Common Stock
Price per share
$547.87Reported price. Read footnotes for ranges.
% of reported position traded
32.49%This security and ownership context
Holdings after
31,764Direct
Trade date
Nov 12, 2026Sell
Filed
Nov 16, 2026, 4:31 PM ET4-day reporting delay
Accession
0000875320-26-000295Code S · Transaction 401894
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 47,050 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

VRTX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
VRTX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 23, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −9.8%1w ago +0.9%1d ago +1.7%
Returns since7d30d90d180d1y

Footnotes in full

F1: Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 8/10/2026.